Pedro Zuzarte, MD, PhD
Supervisor
Professor, Universidade de Lisboa
Medical Doctor and Psychiatrist, Professor of Psychiatry at the Faculty of Medicine, University of Lisbon since 2011, Assistant Professor since 2019. Holds a Doctorate in Medicine (Summa Cum Laude) from the University of Lisbon, with research on neurobiomarkers and the pathophysiology of mood disorders, focusing on cardiovascular and cognitive dysfunctions. Completed a Psychiatry Fellowship at the University of Toronto, a Clinical Research Fellowship at AMRIC, and a Post-Doctoral Fellowship at Health Sciences North, Canada. Trained in Public Health and Alternative Medicine at UFSC, Brazil, where he first engaged with psilocybin as a treatment. Certified in Psychedelic-Assisted Psychotherapy and MDMA-Assisted Therapy by MAPS and CIIS, with training in clinical use of MDMA, Ketamine, and Psilocybin. Studied post-DMT integration under Dr. Gabor Maté. Since 2022, Director of the Ketamine-Assisted Therapy Program (KAT-CC), developing protocols for resistant depression and law enforcement mental health. Holds degrees in Military Medicine and as Senior Medical Officer.
Conflicts of Interest: I declare that I have no conflicts of interest, financial or otherwise, related to the content of this work or to any institution, organization, or company that could inappropriately influence its development or conclusions.